Early research (Phase 1)Study completedNCT00922363
What this trial is testing
Trial on the Safety of a New Liposomal Adjuvant System, CAF01, When Given With the Tuberculosis Subunit Vaccine Ag85B-ESAT-6 as Two Injections With Two Months Interval to Healthy Adult Volunteers
Who this might be right for
Tuberculosis
Statens Serum Institut 38